Ultragenyx Pharmaceutical Inc (RARE)
44.00
-0.10
(-0.23%)
USD |
NASDAQ |
Apr 18, 09:38
Ultragenyx Pharmaceutical Shareholders Equity (Quarterly): 275.41M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 275.41M |
| September 30, 2023 | 31.71M |
| June 30, 2023 | 129.03M |
| March 31, 2023 | 220.48M |
| December 31, 2022 | 352.49M |
| September 30, 2022 | 468.83M |
| June 30, 2022 | 678.07M |
| March 31, 2022 | 796.42M |
| December 31, 2021 | 922.56M |
| September 30, 2021 | 933.67M |
| June 30, 2021 | 972.17M |
| March 31, 2021 | 1.055B |
| December 31, 2020 | 1.154B |
| September 30, 2020 | 666.19M |
| June 30, 2020 | 695.59M |
| March 31, 2020 | 609.15M |
| December 31, 2019 | 653.76M |
| September 30, 2019 | 727.26M |
| June 30, 2019 | 819.79M |
| March 31, 2019 | 886.73M |
| December 31, 2018 | 608.91M |
| September 30, 2018 | 662.60M |
| Date | Value |
|---|---|
| June 30, 2018 | 703.97M |
| March 31, 2018 | 723.66M |
| December 31, 2017 | 383.45M |
| September 30, 2017 | 365.56M |
| June 30, 2017 | 429.45M |
| March 31, 2017 | 488.48M |
| December 31, 2016 | 473.97M |
| September 30, 2016 | 455.89M |
| June 30, 2016 | 443.90M |
| March 31, 2016 | 489.82M |
| December 31, 2015 | 531.09M |
| September 30, 2015 | 576.76M |
| June 30, 2015 | 319.28M |
| March 31, 2015 | 341.12M |
| December 31, 2014 | 184.94M |
| September 30, 2014 | 199.33M |
| June 30, 2014 | 153.08M |
| March 31, 2014 | 165.71M |
| December 31, 2013 | 50.11M |
| September 30, 2013 | 61.15M |
| December 31, 2012 | 84.34M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
31.71M
Minimum
Sep 2023
1.154B
Maximum
Dec 2020
640.08M
Average
678.07M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 506.70M |
| Madrigal Pharmaceuticals Inc | 405.33M |
| Sarepta Therapeutics Inc | 859.34M |
| Rocket Pharmaceuticals Inc | 492.57M |
| Apellis Pharmaceuticals Inc | 194.52M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.491B |
| Total Liabilities (Quarterly) | 1.216B |
| Current Ratio | 2.611 |